A detailed history of Ameriprise Financial Inc transactions in Danaher Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 728,536 shares of DHR stock, worth $168 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
728,536
Previous 807,128 9.74%
Holding current value
$168 Million
Previous $202 Million 0.43%
% of portfolio
0.05%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$239.25 - $280.76 $18.8 Million - $22.1 Million
-78,592 Reduced 9.74%
728,536 $203 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $9.19 Million - $10.5 Million
-39,009 Reduced 4.61%
807,128 $202 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $133 Million - $151 Million
-590,249 Reduced 41.09%
846,137 $211 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $36.6 Million - $46.1 Million
-197,613 Reduced 12.09%
1,436,386 $332 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $23.9 Million - $27.3 Million
102,647 Added 6.7%
1,633,999 $405 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $65.5 Million - $74.5 Million
290,912 Added 23.45%
1,531,352 $368 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $15.1 Million - $17.5 Million
63,062 Added 5.36%
1,240,440 $313 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $64.5 Million - $75.5 Million
267,343 Added 29.38%
1,177,378 $313 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $71.6 Million - $437 Million
-289,967 Reduced 24.16%
910,035 $236 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $36.6 Million - $46.3 Million
-154,394 Reduced 11.4%
1,200,002 $304 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $28.4 Million - $34.9 Million
110,396 Added 8.87%
1,354,396 $395 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $37.3 Million - $42.1 Million
127,851 Added 11.45%
1,244,000 $407 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $39.6 Million - $48.3 Million
-145,355 Reduced 11.52%
1,116,149 $340 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $2.23 Million - $2.69 Million
-9,904 Reduced 0.78%
1,261,504 $339 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $144 Million - $166 Million
-676,342 Reduced 34.72%
1,271,408 $286 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $24.2 Million - $28 Million
114,031 Added 6.22%
1,947,750 $433 Million
Q3 2020

Nov 16, 2020

BUY
$177.16 - $215.33 $152,711 - $185,614
862 Added 0.05%
1,833,719 $395 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $9.74 Million - $13.4 Million
-75,666 Reduced 3.96%
1,832,857 $324 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $23 Million - $32 Million
189,200 Added 11.0%
1,908,523 $264 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $383,459 - $440,948
2,873 Added 0.17%
1,719,323 $264 Million
Q3 2019

Nov 14, 2019

BUY
$135.4 - $146.47 $37.7 Million - $40.8 Million
278,390 Added 19.36%
1,716,450 $248 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $18.8 Million - $21.6 Million
150,502 Added 11.69%
1,438,060 $206 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $34.4 Million - $46.6 Million
352,524 Added 37.7%
1,287,558 $170 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $12,709 - $14,678
134 Added 0.01%
935,034 $96.4 Million
Q3 2018

Nov 14, 2018

SELL
$98.13 - $108.9 $19.5 Million - $21.6 Million
-198,585 Reduced 17.52%
934,900 $109 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $888,732 - $954,763
9,248 Added 0.82%
1,133,485 $112 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $3.54 Million - $3.98 Million
-38,362 Reduced 3.3%
1,124,237 $110 Million
Q4 2017

Feb 12, 2018

SELL
$85.26 - $94.62 $5.73 Million - $6.36 Million
-67,200 Reduced 5.46%
1,162,599 $108 Million
Q3 2017

Nov 07, 2017

BUY
$79.29 - $88.45 $97.5 Million - $109 Million
1,229,799
1,229,799 $106 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.